# Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

> **NCT01207128** · PHASE2 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Aspergillosis

## Interventions

- **DRUG:** Voriconazole, micafungin

## Key facts

- **NCT ID:** NCT01207128
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** None enrolled
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207128, "Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01207128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*